Loading organizations...
§ Venture Capital · Leuven, Vlaams-Brabant, Belgium
Life Sciences Research Partners (LSRP) is a non-profit organization dedicated to fostering scientific inquiry. It promotes, supports, and conducts research, specifically advancing knowledge within biomedical and biotechnological fields. LSRP facilitates critical investigations that contribute to broader scientific understanding.
Professor Désiré Collen established the organization in 1988 as the D. Collen Research Foundation, evolving into LSRP in 2007. Collen, a distinguished scientist with an MD and PhD, founded it to systematically promote research by financing fellowships. His background, including the 1979 discovery of tissue-type plasminogen activator, underscored this mission.
LSRP serves the scientific community by empowering researchers across life sciences. Its vision centers on championing and enabling fundamental and applied research, particularly in biomedical and biotechnological domains. Through this commitment, LSRP aims to contribute significantly to advancements in health and technology, fostering an environment for critical discoveries.
Life Sciences Research Partners has 3 tracked investments across 2 companies. The latest tracked deal is $10.4M Grant / Series D in Bone Therapeutics in January 2013.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 28, 2013 | Bone Therapeutics | $10.4M Grant / Series D | — | Bams Angel Fund, Nausicaa Ventures, Sambrinvest, Sriw |
| Mar 28, 2012 | Promethera Biosciences | $31.4M Debt / Series B | — | Atmi, Boehringer Ingelheim, Financière Spin OFF Luxembourgeoise, Mitsui & CO. Global Investment, Nivelinvest, Sambrinvest, Shire, Sopartec, Sriw, Vesalius Biocapital, Vives Louvain Technology Fund, Walloon Region |
| Nov 9, 2009 | Promethera Biosciences | $8.0M Series A | Vesalius Biocapital | Capital Croissance, LRM, Nivelinvest, Sopartec, Sriw, Vives Louvain Technology Fund |